Genmab Investor Relations Material
Latest events
Q1 2025
Genmab
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Genmab
Access all reports
Segment Data
Access more data
Revenue by
Type
Royalties
Milestone revenue
Reimbursement revenue
Collaboration revenue
License revenue
Expenses by
Financials
Genmab, a biotechnology company, develops antibody therapeutics for the treatment of cancer and other diseases primarily in Europe.
Key slides for Genmab
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
GMAB
Country
🇩🇰 Denmark